tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LTRN Stock Latest News

Lantern Pharma announces LP-184 clinical trial met all primary endpoints
The FlyLantern Pharma announces LP-184 clinical trial met all primary endpoints
10d ago
LTRN
Lantern Pharma’s Q3 2025: Clinical and AI Progress
PremiumCompany Announcements
Lantern Pharma’s Q3 2025: Clinical and AI Progress
29d ago
LTRN
Lantern Pharma’s Earnings Call: Progress and Funding Needs
PremiumCompany Announcements
Lantern Pharma’s Earnings Call: Progress and Funding Needs
29d ago
LTRN
Lantern Pharma Achieves Key Milestones in Q3 2025
PremiumCompany Announcements
Lantern Pharma Achieves Key Milestones in Q3 2025
30d ago
8K
LTRN
Lantern Pharma management to meet virtually with Lake Street
PremiumThe Fly
Lantern Pharma management to meet virtually with Lake Street
1M ago
LTRN
Is LTRN a Buy, Before Earnings?
PremiumPre-EarningsIs LTRN a Buy, Before Earnings?
1M ago
LTRN
Lantern Pharma engages New to The Street for media program
Premium
The Fly
Lantern Pharma engages New to The Street for media program
1M ago
LTRN
Lantern Pharma presents clinical data from LP-284
Premium
The Fly
Lantern Pharma presents clinical data from LP-284
2M ago
LTRN
Lantern Pharma’s Promising Phase II Lung Cancer Study: Key Insights for Investors
PremiumCompany Announcements
Lantern Pharma’s Promising Phase II Lung Cancer Study: Key Insights for Investors
2M ago
LTRN
Lantern Pharma’s LP-284 Study: A Potential Game-Changer in Cancer Treatment?
PremiumCompany Announcements
Lantern Pharma’s LP-284 Study: A Potential Game-Changer in Cancer Treatment?
2M ago
LTRN
Lantern Pharma’s LP-184 Study: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
Lantern Pharma’s LP-184 Study: A Potential Game-Changer in Cancer Treatment
2M ago
LTRN
Lantern Pharma Holds Annual Stockholders Meeting
PremiumCompany Announcements
Lantern Pharma Holds Annual Stockholders Meeting
3M ago
8K
LTRN
Lantern Pharma announces LP-184 trial met all primary endpoints
PremiumThe FlyLantern Pharma announces LP-184 trial met all primary endpoints
3M ago
LTRN
Lantern Pharma trading resumes
Premium
The Fly
Lantern Pharma trading resumes
3M ago
LTRN
Lantern Pharma trading halted, news pending
Premium
The Fly
Lantern Pharma trading halted, news pending
3M ago
LTRN
Lantern Pharma announces completion of Type C meeting with FDA
PremiumThe Fly
Lantern Pharma announces completion of Type C meeting with FDA
3M ago
LTRN
Lantern Pharma Reports Q2 2025 Earnings and Strategic Progress
PremiumCompany Announcements
Lantern Pharma Reports Q2 2025 Earnings and Strategic Progress
4M ago
LTRN
Lantern Pharma completes targeted enrollment for HARMONIC trial
PremiumThe Fly
Lantern Pharma completes targeted enrollment for HARMONIC trial
4M ago
LTRN
Lantern Pharma Appoints Dr. Schalop to Board
PremiumCompany Announcements
Lantern Pharma Appoints Dr. Schalop to Board
5M ago
8K
LTRN
Lantern reports complete response in pretreated Lymphoma patient with LP-284
PremiumThe FlyLantern reports complete response in pretreated Lymphoma patient with LP-284
5M ago
LTRN
Lantern Pharma issued notice of allowance by EPO for LP-284 patent
Premium
The Fly
Lantern Pharma issued notice of allowance by EPO for LP-284 patent
5M ago
LTRN
Lantern Pharma launches AI-powered module within RADR platform
Premium
The Fly
Lantern Pharma launches AI-powered module within RADR platform
5M ago
LTRN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >